Denintuzumab (Anti-CD19)Denintuzumab (Anti-CD19)
Move your mouse over image or click to enlarge

Denintuzumab (Anti-CD19)

Denintuzumab (anti-CD19) is a recombinant humanized anti-CD19 monoclonal antibody that can be used in the research of acute lymphoblastic leukemia. Denintuzumab can be used to synthesize ADC antibody Denintuzumab Mafodotin (SGN-CD19A). MW: 145.0 kD.
Cat# Size Price Qty Buy
A2795-1mg*25 1mg*25
£2,432.00
A2795-1mg*5 1mg*5
£794.00
A2795-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2795

Related Documents